Home » News » Announcements
Jul 22, 2013, 03.48 PM IST | Source: Moneycontrol.com

Lupin receives FDA approval for Generic GIumetza extended-release tablets

Lupins US subsidiary, Lupin Pharmaceuticals, Inc (LPI) has received final approval for its Metformin Hydrochloride extended release tablets 500 mg and 1000 mg from United States Food and Drugs Administration.

Lupin Ltd has informed BSE regarding a Press Release dated July 22, 2013, titled "Lupin receives FDA approval for Generic GIumetza extended-release Tablets" Lupins US subsidiary, Lupin Pharmaceuticals, Inc (LPI) has received final approval for its Metformin Hydrochloride extended release tablets 500 mg and 1000 mg from United States Food and Drugs Administration.Source : BSE

Read all announcements in Lupin

To read the full report click here

Set email alert for

ADS BY GOOGLE

Buy & sell politicians on Power Play
- the political stock exchange

Price Update

Rahul Gandhi

600.02 2.91 0.49%

180856

Bought today

113378

Sold today

0.42%

User holding

video of the day

Ambit Cap eyes two years of market cheer; bets on cyclicals

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.